Background & aims Coronavirus disease 2019 (COVID-19) patients with severe
complications have shown comorbidities with cardiovascular-disease, hypertension and …

Summary Background Coronavirus disease-2019 (COVID-19) is a global pandemic. Studies
reported dyslipidemia in patients with COVID-19. Herein, we conducted a systematic review …

Background COVID-19 has been recognized as an emerging and rapidly evolving health
condition. For this reason, efforts to determine changes in laboratory parameters of COVID …

Background Dyslipidemia has been observed in patients with coronavirus disease 2019
(COVID‐19). This study aimed to investigate blood lipid profiles in patients with COVID‐19 …

Coronavirus disease (COVID)-19, as a result of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection, has been the direct cause of over 2.2 million deaths …

Introduction: Similar to what it has been reported with preceding viral epidemics (such as
MERS, SARS, or influenza), SARS-CoV-2 infection is also affecting the human …

Background The numbers of confirmed cases of coronavirus disease 2019 (COVID-19) and
COVID-19 related deaths are still increasing, so it is very important to determine the risk …

The outbreak of the coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has become a worldwide public health …

Background. Metabolic alterations, particularly disorders of lipoprotein metabolism in COVID‐
19, may affect the course and outcome of the disease. This study aims at evaluating the …

Dear Editor, As of July, 2020, the ongoing pandemic of coronavirus diseases 2019 (COVID-
19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 …